The largest database of trusted experimental protocols

Methyl thiazolyl tetrazolium (mtt)

Manufactured by Agilent Technologies
Sourced in United States

The MTT is a laboratory equipment product designed for cell proliferation and cytotoxicity assays. It is a colorimetric assay that measures the activity of cellular enzymes, which can indirectly reflect the number of viable cells in a sample.

Automatically generated - may contain errors

68 protocols using methyl thiazolyl tetrazolium (mtt)

1

Evaluating Cell Toxicity of Antiviral Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell toxicity of 6MMPr and RIB was tested on growing cells via in situ mitochondrial reduction of a tetrazolium dye, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma, St. Louis, USA). Briefly, VerodogSLAM cells (1 × 104 cells/well) were seeded on 96-well microplates for 24 h. The medium was replaced with 200 μL fresh DMEM containing different concentrations of the compounds. After 72 h of incubation at 37 °C, the culture medium was removed and replenished with 50 μL of MTT working solution (1 mg/mL) to each well and the microplate was incubated for 4 h. MTT formazan crystals were solubilized by adding DMSO (dimethyl sulfoxide) and the optical densities were determined spectrophotometrically with an absorbance microplate reader (BioTek, ELX800, Winooski, Vermont, USA) at 540 nm. Cell viability was calculated by subtracting the optical density fraction of treated cells from the untreated cells. The cytotoxic concentration for 50% of the cell culture (CC50) was expressed as the compound concentration required to reduce the absorbance of treated cells by 50% in comparison to control cells. CC20 was defined as the limit point for treatment with the antiviral molecules [22 (link)]. At least two independent experiments were performed with eight replicates for each concentration level.
+ Open protocol
+ Expand
2

MCDC Inhibits Cell Viability in Vitro

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at a density of 3,000 cells per well in 96-well microplate and treated with 2–8 μM 1-(9′-methyl-3′-carbazole)-3, 4-dihydro-β-carboline (MCDC) 24 h after seeding. The testing concentration of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT; BioTek, Winooski, VT, USA) was 0.456 mg/mL. Cells were kept at this concentration of MTT at 37 °C, 5% CO2 for 1.5 h, then dissolved in 100 μL DMSO per well. The absorbance values were measured 48 h after MCDC treatment using a microtiter plate reader (BioTek) at 570 nm.
+ Open protocol
+ Expand
3

Cell Proliferation Assays: MTT and Alamar Blue

Check if the same lab product or an alternative is used in the 5 most similar protocols
The proliferation rates of each cell were determined by MTT (Sigma, St. Louis, MO, USA) and Alamar Blue (Invitrogen, Carlsbad, CA, USA). For the MTT test, 100 μL of MTT (1 mg/ml) solution was added into 96-well plates and incubated at 37 °C for 2 h. After removing media, 100 μL of isopropanol/1N HCl (v:v = 24:1) was added into each well to dissolve formazan crystals, and the absorbance at 570 nm was measured by a microplate reader (BioTek Epoch, Winooski, VT, USA). For the Alamar Blue assay, 100 μL of Alamar Blue (10% in medium) was added into 96-well plates and incubated at 37 °C for 2 h. Then, the absorbance of Alamar Blue solution was measured by a microplate reader (BioTek Epoch) at 600 nm.
+ Open protocol
+ Expand
4

Assessing 6MMPr Cytotoxicity in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell toxicity of 6MMPr was tested on growing cells via in situ mitochondrial reduction of a tetrazolium dye 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma, St. Louis, USA). Briefly, 24 h-plated Vero (1x10 4 cells/well) and SH-SY5Y cells (4x10 4 cells/well) in 96-well microplates were treated with various concentrations of the test compound. After 72 h (SH-SY5Y cells) and 120 h (Vero cells) of incubation at 37 °C, culture medium was removed and replenished with 50 μL of MTT solution (1 mg/mL) to each well and the microplate was incubated for 4 h. MTT formazan crystals were solubilized by adding DMSO and the optical densities were determined spectrophotometrically with a 96-well plate reader (BioTek, ELX800, Winooski, USA) at 540 nm. As a control for the cytotoxicity test, ribavirin was used at various concentrations (10 to 100 μM ). Cell viability was calculated by subtracting the optical density fraction of treated cells from the untreated cells. Cytotoxic concentration for 50% of cell culture (CC 50 ) was defined as the concentration of the compound that caused a 50% reduction in absorbance. CC 20 was defined as the limit point for treatment with the antiviral molecules [24] .
+ Open protocol
+ Expand
5

Evaluating Cell Viability with T-5224, RSPO2, and AZD5363

Check if the same lab product or an alternative is used in the 5 most similar protocols
The FPA cells (GT1-1, GH3) were plated into 96-well culture plate with a density of 500 cells/well, and were treated with different doses of T-5224, RSPO2, and AZD5363, respectively, as well as STO-609 (CaMKK inhibitor) and Genipin (aglycone derived from the iridoid glycoside), both of which protect against several types of tumors, including brain tumors. We used MTT (Sigma, St. Louis, Missouri, USA) dissolved in PBS (5 mg/ml) to measure the viability of cells. On the day of measurement, the medium was replaced on fresh DMEM supplemented with 10% FBS and diluted MTT (1:10, 10% MTT), and incubated for 3.5 h at 37 °C. Then, the incubation medium was removed and formazan crystals were dissolved in 200 μl solution of DMSO. We used an ELx800 absorbance microplate reader (BioTek Instruments, VT, USA) to quantify the MTT reduction by measuring light absorbance at 570 nm. Each test was repeated four times.
+ Open protocol
+ Expand
6

Evaluating Metabolic Activity in Porous Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate the metabolically active MC3T3-E1 cells on and within the porous scaffolds, a MTT assay was conducted to determine cell proliferation. At designated time of 1, 3 and 7 days, the cell-seeded scaffolds and control wells were placed in 400 μl serum-free medium containing 100 μg of the tetrazolium salt MTT (Sigma, USA; 5mg/ml) for the last 4 h of incubation to permit visualization of metabolically active cells. After the incubation, the scaffolds were briefly rinsed in warm PBS and blotted dry. The insoluble purple formazan, a product of mitochondrial MTT metabolism, was extracted from the scaffolds with 1.0 ml ethanol and measured spectrophotometrically for optical density (OD) values at 490 nm in microplate reader (Bio-Tek, USA).
+ Open protocol
+ Expand
7

MTT Cell Proliferation Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell proliferation assay was performed using MTT (Sigma-Aldrich Co., St Louis, MO, USA). Cells were seeded in 96-well plates at various densities (3 × 104/mL, 5 × 103/mL, and 1.5 × 103/mL), and treated with different compounds at various concentrations, for different intervals (24, 48, and 72 hours, respectively). The MTT solution was added to each well at the final concentration of 0.5 mg/mL. After incubation for 4 hours at 37°C, the absorbance was measured at 570 nm using a microplate reader (Biotek Instruments, Inc., Winooski, VT, USA). The IC50 values were calculated using Graphpad Prism 5 Software (GraphPad Software, San Diego, CA, USA).
+ Open protocol
+ Expand
8

Cytotoxicity Evaluation of Bioresorbable Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs; ATCC, Manassas, VA) were expanded in growth media consisting of Endothelial Cell Growth Kit-VEGF (ATCC® PCS-100-041) in Vascular Cell Basal Medium (ATCC® PCS-100-030) under the standard culture condition (37 °C with 5% CO2 in a humid environment) to 80% confluency before passaging. HUVECs at passages 5-7 were used.
The effect of the iodixanol introduction on the cytotoxicity of BRS was evaluated by means of an indirect cytotoxicity assay following ISO 10993-5: 2009. Specifically, the BRS were first sterilized by Ethylene Oxide and 0.5 mL of growth media was incubated with BRS for 24 hours at 37 °C with agitation. Next, the liquid extracts of different BRS were collected and added to HUVECs at sub-confluence in 24-well pates. After incubation for 24 hours, cells were incubated with growth media containing 0.5 mg/mL MTT (Thermo Fisher Scientific, San Jose, CA) for 3 hours. After replacing the MTT solution with DMSO, the plate was shaken for 15 min to solubilize the formazan crystals, and the absorbance of each well was measured at 570 nm using a microplate reader Cytation 5 (BioTek Instruments). The number of viable cells per well was calculated against a standard curve prepared by plating various concentrations of isolated cells, as determined by hemocytometer, in triplicate in the culture plates.
+ Open protocol
+ Expand
9

Astrocyte Viability Assay with Histamine

Check if the same lab product or an alternative is used in the 5 most similar protocols
The astrocytes at 3 × 105/ml were sub-cultured in 10−7 mol/L histamine for 30 min on 96-well culture plates, which were previously coated by poly-L-lysine or laminin38 (link). After repeated wash with PBS, the cells were incubated with MTT (Sigma, USA, 0.5 mg/mL as final concentration) for 4 h at 37 °C. Then, the supernatant layer was removed, and 100 μL of dimethyl sulfoxide was added to each well. MTT metabolism was quantified spectrophotometrically at 570 nm by a Biotek microplate reader (USA).
+ Open protocol
+ Expand
10

Cell Viability Assay via MTT

Check if the same lab product or an alternative is used in the 5 most similar protocols
The in vitro cell viability test was performed with a MTT assay as described previously [43 (link), 44 (link)]. 24 h post transfection, cells were seeded in 96-well culture plates (4 × 103/well) for 12 h, 24 h, 36 h, 48 h, and 60 h (in triplicate for each condition). 20 µl MTT (Sigma, Saint Louis, USA) stock solution (5 mg/ml) was added to each well and incubated for 2–3 h. Then, the supernatant was removed, followed by the solubilisation of MTT crystals using DMSO and the absorbance was measured at 570 nm using plate reader BioTek Eon (BioTek, Winooski, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!